BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34343822)

  • 1. Role of heparanase 2 (Hpa2) in gastric cancer.
    Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
    Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
    Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.
    Knani I; Singh P; Gross-Cohen M; Aviram S; Ilan N; Sanderson RD; Aronheim A; Vlodavsky I
    Matrix Biol; 2022 Jan; 105():17-30. PubMed ID: 34808335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.
    Gross-Cohen M; Feld S; Naroditsky I; Nativ O; Ilan N; Vlodavsky I
    Oncotarget; 2016 Apr; 7(16):22556-65. PubMed ID: 26968815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma.
    Kayal Y; Singh P; Naroditsky I; Ilan N; Vlodavsky I
    Matrix Biol; 2021 Apr; 98():21-31. PubMed ID: 33839221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
    Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
    FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.
    Gross-Cohen M; Yanku Y; Kessler O; Barash U; Boyango I; Cid-Arregui A; Neufeld G; Ilan N; Vlodavsky I
    Matrix Biol; 2021 May; 99():58-71. PubMed ID: 34004353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.
    Margulis I; Naroditsky I; Gross-Cohen M; Ilan N; Vlodavsky I; Doweck I
    Front Oncol; 2021; 11():645524. PubMed ID: 33959505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis.
    Hilwi M; Shulman K; Naroditsky I; Feld S; Gross-Cohen M; Boyango I; Soboh S; Vornicova O; Farhoud M; Singh P; Bar-Sela G; Goldberg H; Götte M; Sharrocks AD; Li Y; Sanderson RD; Ilan N; Vlodavsky I
    Cell Death Dis; 2024 Mar; 15(3):232. PubMed ID: 38519456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase 2 (Hpa2) attenuates the growth of human sarcoma.
    Knani I; Yanku Y; Gross-Cohen M; Ilan N; Vlodavsky I
    Matrix Biol; 2022 Nov; 113():22-38. PubMed ID: 36122821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
    Levy-Adam F; Feld S; Cohen-Kaplan V; Shteingauz A; Gross M; Arvatz G; Naroditsky I; Ilan N; Doweck I; Vlodavsky I
    J Biol Chem; 2010 Sep; 285(36):28010-9. PubMed ID: 20576607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.
    Gross-Cohen M; Feld S; Arvatz G; Ilan N; Vlodavsky I
    Front Oncol; 2020; 10():627463. PubMed ID: 33585253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.
    Kayal Y; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cell Death Dis; 2023 Jul; 14(7):465. PubMed ID: 37491420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
    Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
    Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma].
    Ren XL; Zhu RZ; Wang LJ; Zhang ML; Li DH; Deng XQ
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):368-71. PubMed ID: 12921569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
    Doweck I; Feibish N
    Adv Exp Med Biol; 2020; 1221():847-856. PubMed ID: 32274741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase gene expression and metastatic potential in human gastric cancer.
    Endo K; Maejara U; Baba H; Tokunaga E; Koga T; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Nakajima M; Sugimachi K
    Anticancer Res; 2001; 21(5):3365-9. PubMed ID: 11848495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heparanase system and tumor metastasis: is heparanase the seed and soil?
    Arvatz G; Shafat I; Levy-Adam F; Ilan N; Vlodavsky I
    Cancer Metastasis Rev; 2011 Jun; 30(2):253-68. PubMed ID: 21308479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase expression correlates with invasion and poor prognosis in gastric cancers.
    Takaoka M; Naomoto Y; Ohkawa T; Uetsuka H; Shirakawa Y; Uno F; Fujiwara T; Gunduz M; Nagatsuka H; Nakajima M; Tanaka N; Haisa M
    Lab Invest; 2003 May; 83(5):613-22. PubMed ID: 12746471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.